DocSlides is a free service to upload presentations and documents.
DocSlides is a free service to upload presentations and documents.
Elbasvir Sofosbuvir published presentations and documents on DocSlides.
JAMA 20153131232 9 HIV Coinfection brPage 2br Sou...
+ Sofosbuvir in HCV GT 1-4 and HIV Coinfection. A...
. + . Sofosbuvir. in Genotype . 3. ALLY-3 Study...
ELECTRON (Overview): 6 parts, 22 arms. Phase . 2....
VALENCE Trial Phase 3 Treatment Na
Developed by Camilla S. Graham, MD, BIDMC, 5/5/15...
John J. . Faragon. , . PharmD. , BCPS, AAHIV-P. R...
Design. C-SCAPE . Study. : . grazoprevir. ± . e...
C-WORTHY Study Part C: . grazoprevir. . + . elba...
grazoprevir. . + . elbasvir. . in genotype 1 wi...
+ Ribavirin to Prevent Post-Transplant HCV Recur...
With Or Without Ribavirin Is Safe and Efficacious...
Hepatitis-2015. Orlando. , USA. July 20 - 22 20...
Design. C-SCAPE . Study. : . grazoprevir. ± . e...
D : . grazoprevir. . + . elbasvir. + RBV in ge...
+ Sofosbuvir in HCV GT 1-4 and HIV Coinfection. A...
(. Epclusa. ). Prepared by. : H. Nina Kim, MD MS...
. +/- Ribavirin in HCV Genotype 1, 4 or 6. C-EDG...
. + Sofosbuvir +/- Ribavirin in Genotype 1. COS...
Matthew Luu, Yuan Fang (Pearl) Cai, Shiming Sun, ...
. and HIV Coinfection. NIAID ERADICATE Trial. Ph...
Genotype . 2. . or 3 . FUSION. Trial. Phase . ...
ION-4. Phase . 3. Treatment. Naïve and Treatmen...
NIH SPARE. Phase . 2. Treatment. . Naïve . (unf...
HIV Coinfection & HCV . GT 1,2,3. PHOTON-1 Tr...
+ . Grazoprevir. +/- Ribavirin in . Treatment-N...
SIRIUS. Phase . 2 . Treatment. . Experienced. Bo...
+ . Grazoprevir. in . GT 1 . and Chronic Renal ...
. + . Sofosbuvir. . in Treatment-Naïve HCV Gen...
Harvoni. ). Prepared by: . David H. Spach, MD and...
With Or Without Ribavirin Is Safe and Efficacious...
6; 386:1537-45. C-SURFER Study: . grazoprevir. ....
rd. DAA in HCV Genotype 1 . NIAID SYNERGY: Genot...
VALENCE Trial. Phase . 3. Treatment. Naïve and ...
X. J . Hepatology. 2015; 63: 564-72. C-SALVAGE ...
in genotypes 1 or 3, with or without cirrhosis. &...
David Spach, MD. Clinical Director, Northwest AET...
Randomisation*. Open-label. >. 18 years. HCV ...
. or 3 . LONESTAR-2. Phase 2. Treatment. . Exp...
Updated: . July . 6. , . 2015. Treatment of Hepat...
Copyright © 2024 DocSlides. All Rights Reserved